Skip to content

Clinical trials

Phase 2 Adenocarcinoma trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 2 Country / region: Taiwan Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20071
20081
20161
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Completed3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
EMD Serono Research & Development Institute, Inc.1
Maia Biotechnology1
National Health Research Institutes, Taiwan1
Novartis Pharmaceuticals1
PharmaEngine1
Taipei Veterans General Hospital, Taiwan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma7
Carcinoma, Non-Small-Cell Lung3
Carcinoma2
Esophageal Neoplasms2
Stomach Neoplasms2
Carcinoma, Large Cell1
Carcinoma, Renal Cell1
Carcinoma, Squamous Cell1
Colonic Diseases1
Margins of Excision1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.